Comparative Pharmacovigilance Analysis of Selected Cardiotoxicity Signals Associated with Doxorubicin and Epirubicin Based on EudraVigilance Data.

Fiat ES, Butuca A, Dobrea CM, Ghibu S, Vonica RC, Frum A, Morgovan C, Palade NA, Solomon CC, Batar F, Vintila BI, Totan M, Gligor FG

Open source

DOI: 10.3390/jcm15176734
Published: 2026 Aug 30
Container: Journal of clinical medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/jcm15176734,
  title = {Comparative Pharmacovigilance Analysis of Selected Cardiotoxicity Signals Associated with Doxorubicin and Epirubicin Based on EudraVigilance Data.},
  author = {Fiat ES and Butuca A and Dobrea CM and Ghibu S and Vonica RC and Frum A and Morgovan C and Palade NA and Solomon CC and Batar F and Vintila BI and Totan M and Gligor FG},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15176734},
  url = {https://doi.org/10.3390/jcm15176734}
}

RIS

TY  - JOUR
TI  - Comparative Pharmacovigilance Analysis of Selected Cardiotoxicity Signals Associated with Doxorubicin and Epirubicin Based on EudraVigilance Data.
AU  - Fiat ES
AU  - Butuca A
AU  - Dobrea CM
AU  - Ghibu S
AU  - Vonica RC
AU  - Frum A
AU  - Morgovan C
AU  - Palade NA
AU  - Solomon CC
AU  - Batar F
AU  - Vintila BI
AU  - Totan M
AU  - Gligor FG
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15176734
UR  - https://doi.org/10.3390/jcm15176734
ER  -

APA

ES, F., A, B., CM, D., S, G., RC, V., A, F., C, M., NA, P., CC, S., F, B., BI, V., M, T., & FG, G. (2026). Comparative Pharmacovigilance Analysis of Selected Cardiotoxicity Signals Associated with Doxorubicin and Epirubicin Based on EudraVigilance Data.. Journal of clinical medicine. https://doi.org/10.3390/jcm15176734

Source records

pubmed · retrieved 2026-09-24T19:54:26.398Z